ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
about
Calretinin as a blood-based biomarker for mesotheliomaMalignant Mesothelioma: Time to Translate?Erratum to: ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers
P2860
ENOX2-based early detection (ONCOblot) of asbestos-induced malignant mesothelioma 4-10 years in advance of clinical symptoms.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
ENOX2-based early detection (O ...... advance of clinical symptoms.
@ast
ENOX2-based early detection (O ...... advance of clinical symptoms.
@en
type
label
ENOX2-based early detection (O ...... advance of clinical symptoms.
@ast
ENOX2-based early detection (O ...... advance of clinical symptoms.
@en
prefLabel
ENOX2-based early detection (O ...... advance of clinical symptoms.
@ast
ENOX2-based early detection (O ...... advance of clinical symptoms.
@en
P2093
P2860
P1433
P1476
ENOX2-based early detection (O ...... advance of clinical symptoms.
@en
P2093
Brandon Hostetler
Bruce W S Robinson
D James Morré
David J Taggart
Dorothy M Morré
Jenette Creaney
P2860
P2888
P356
10.1186/S12014-016-9103-3
P577
2016-01-22T00:00:00Z
P5875
P6179
1027168148